Menu

Blog

Archive for the ‘bioengineering’ category: Page 166

Dec 22, 2016

UW researcher pursues synthetic ‘scaffolds’ for muscle regeneration

Posted by in category: bioengineering

Tissue engineering for muscles.


Tissue engineering in the news again this time its creating scaffolds for muscle regeneration.

Read more

Dec 22, 2016

The UN Just Gave Scientists the Green Light to Mess With Natural Selection

Posted by in categories: bioengineering, genetics

Of all the potentially apocalyptic technologies scientists have come up with in recent years, the gene drive is easily one of the most terrifying. A gene drive is a tool that allows scientists to use genetic engineering to override natural selection during reproduction. In theory, scientists could use it to alter the genetic makeup of an entire species—or even wipe that species out. It’s not hard to imagine how a slip-up in the lab could lead to things going very, very wrong.

Read more

Dec 20, 2016

CRISPR gene editing human trials in China and US offer hope for countless lives

Posted by in categories: bioengineering, biotech/medical, genetics

The biotech battle between China and the US has begun as we predicated when we announced the first CRISPR deployment in humans last month. The US has upped the ante and is taking a step further in the race for the biotech crown. All great news for us as the more competition the faster progress will move so let’s hope there is a fierce battle for biotech coming.


In 2015, a little girl called Layla was treated with gene-edited immune cells that eliminated all signs of the leukemia that was killing her. Layla’s treatment was a one-off, but by the end of 2017, the technique could have saved dozens of lives.

It took many years to develop the gene-editing tool that saved Layla, but thanks to a revolutionary method known as CRISPR, this can now be done in just weeks.

Continue reading “CRISPR gene editing human trials in China and US offer hope for countless lives” »

Dec 17, 2016

The disturbingly accurate brain science that identifies potential criminals while they’re still toddlers

Posted by in categories: bioengineering, health, neuroscience, science

Scientists are able to use brain tests on three-year-olds to determine which children are more likely to grow up to become criminals. It sounds like Minority Report come to life: An uncomfortable idea presenting myriad ethical concerns. But, though unnerving, the research is nuanced and could potentially be put to good use.

In the study, published in Nature Human Behavior this week, researchers led by neuroscientists at Duke University showed that those with the lowest 20% brain health results aged three went on to commit more than 80% of crimes as adults. The research used data from a New Zealand longitudinal study of more than 1,000 people from birth in the early 1970s until they reached 38 years old. This distribution, of 20% of a population accounting for 80% of an effect, is strong but not unusual. In fact, it follows the “Pareto principle.” The authors write in their paper:

In Pareto’s day, the problem definition was that 20% of families owned 80% of land in Italy. The so-called Pareto principle is alive and useful today: for example, in software engineering, 20% of the code is said to contain 80% of the errors.

Continue reading “The disturbingly accurate brain science that identifies potential criminals while they’re still toddlers” »

Dec 17, 2016

Can we engineer the end of ageing?

Posted by in categories: bioengineering, biotech/medical, life extension

Biologist Daisy Robinton talks about engineering aging and the possibilities new technology offers.


Harvard University biologist Daisy Robinton reveals how science is helping us understand how and why we age.

Continue reading “Can we engineer the end of ageing?” »

Dec 16, 2016

CellAge – Synthetic biology meets senolytics

Posted by in categories: bioengineering, biotech/medical, life extension

Check out the LEAF interview with Synthetic Biology company CellAge who plan to use their technology to create aging biomarkers for the research community to use for free as well as new approaches to removing senescent cells.


CellAge are using synthetic biology to remove senescent cells that accumulate with age and contribute to disease. We took the time to interview them about their technology, treating age-related diseases and their plans for the future.

You can also check out their campaign on Lifespan.io:

Continue reading “CellAge – Synthetic biology meets senolytics” »

Dec 15, 2016

Gene editing takes on new roles

Posted by in categories: bioengineering, biotech/medical, genetics, neuroscience

What combinations of mutations help cancer cells survive? Which cells in the brain are involved in the onset of Alzheimer’s? How do immune cells conduct their convoluted decision-making processes? Researchers at the Weizmann Institute of Science have now combined two powerful research tools — CRISPR gene editing and single cell genomic profiling — in a method that may finally help us get answers to these questions and many more.

The new technology enables researchers to manipulate gene functions within single cells, and understand the results of each change in extremely high resolution. A single experiment with this method, say the scientists, may be equal to thousands of experiments conducted using previous approaches, and it may advance the field of genetic engineering for medical applications.

The gene-editing technique CRISPR is already transforming biology research around the world, and its clinical use in humans is just around the corner. CRISPR was first discovered in bacteria as a primitive acquired immune system, which cuts and pastes viral DNA into their own genomes to fight viruses. In recent years, this bacterial system has been adopted by researchers to snip out or insert nearly any gene in any organism or cell, quickly and efficiently. “But CRISPR, on its own, is a blunt research tool, since we often have trouble observing or understanding the outcome of this genomic editing,” says Prof. Ido Amit of the Weizmann Institute of Science’s Immunology Department, who led the study. “Most studies so far have looked for black-or-white types of effects,” adds Dr. Diego Jaitin, of Amit’s lab group, “but the majority of processes in the body are complex and even chaotic.”

Read more

Dec 15, 2016

Will Gene-Editing Technologies Spark the Next Cold War? They Already Have

Posted by in categories: bioengineering, biotech/medical, genetics, transhumanism

Excellent article by Nick Gillespie, Editor-in Chief of Reason. Genetic editing is so far the 21st Century’s most important science—and it’s already being challenged by many as too radical: http://reason.com/blog/2016/12/15/will-gene-editing-technologies-spark-the #transhumanism #CRISPR #Future


The folks behind CRISPR gene editing were runners-up for Time’s Person of the Year. Their creation may win the future for secular China.

Continue reading “Will Gene-Editing Technologies Spark the Next Cold War? They Already Have” »

Dec 14, 2016

CellAge: Senescent Cell Targeting Technology Video

Posted by in categories: bioengineering, biotech/medical, finance, genetics, health, life extension

Synthetic biology meets senolytics at Lifespan.io

We are developing tools to help researchers accurately target and remove dysfunctional cells in the body that have entered a state called “senescence”, and thereby assist in restoring it to youthful functionality. Please subscribe, share, and fund our campaign today! ►Campaign Link: https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/ ►Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1

Continue reading “CellAge: Senescent Cell Targeting Technology Video” »

Dec 14, 2016

CellAge: Dr. Aubrey de Grey Endorsement Video

Posted by in categories: bioengineering, biotech/medical, finance, genetics, health, life extension

Dr. Aubrey de Grey from the SENS Research Foundation was kind enough to talk in support of CellAge and their campaign on Lifespan.io

We are developing tools to help researchers accurately target and remove dysfunctional cells in the body that have entered a state called “senescence”, and thereby assist in restoring it to youthful functionality. Please subscribe, share, and fund our campaign today! ►Campaign Link: https://www.lifespan.io/campaigns/cellage-targeting-senescen…c-biology/ ►Subscribe: https://www.youtube.com/user/LifespanIO?sub_confirmation=1

Continue reading “CellAge: Dr. Aubrey de Grey Endorsement Video” »